Treatment Settings for Substance Use Problems

2019 ◽  
pp. 35-40
Author(s):  
Dennis C. Daley ◽  
Antoine Douaihy
Keyword(s):  
Substance Use ◽  
Early Intervention ◽  
Substance Use Disorder ◽  
Continuum Of Care ◽  
Continuing Care ◽  
Inpatient Hospital ◽  
Levels Of Care ◽  
Rehabilitation Programs ◽  
Substance Use Problems ◽  
Residential Rehabilitation

A continuum of care is needed to meet the needs of clients with substance use problems. The least restrictive level of treatment should be used unless the severity of the diagnosed substance use disorder (SUD) and related medical, psychiatric, and social problems are such that medically managed or monitored treatment is needed. Levels of care include early intervention, outpatient and aftercare or continuing care programs, non-residential addiction rehabilitation programs, and inpatient hospital and residential rehabilitation programs.

scholarly journals General practice patients starting treatment for substance use problems: observations from two data sources across levels of care

2020 ◽  
Author(s):  
Nicole Boffin ◽  
Jerome Antoine ◽  
Luk Van Baelen ◽  
Sarah Moreels ◽  
Kris Doggen
Keyword(s):  
General Practice ◽  
Substance Use ◽  
Data Sources ◽  
Treatment Episode ◽  
Specialist Care ◽  
Levels Of Care ◽  
Substance Use Problems ◽  
Stable Housing ◽  
Treatment Demand ◽  
Specialist Treatment

Abstract BackgroundIn Belgium, the incidence of treatment episodes for substance use problems is monitored by the Network of Sentinel General Practices (SGP) and by the Treatment Demand Indicator (TDI) surveillance at higher, specialist care levels. Using both data sources, we examine 1) how patients starting specialist treatment for substance use problems on referral by their GP compare to those that were referred by non-GP caregivers; 2) how patients starting GP treatment for substance use problems without receiving specialist treatment concurrently compare to those who do.MethodsThe same European protocol with common variables was used by both surveillances. Data from 2016 and 2017 were examined using 95% confidence intervals and multivariate regression.ResultsAccording to TDI-data (n=16,543), determinants of being referred by a GP (versus by a non-GP caregiver) for specialist treatment were age ≥ median (OR 1.25; 95% CI 1.13-1.38), education ≥ secondary level (OR 1.27; 95% CI 1.15-1.41), recent employment (OR 1.71; 1.56-1.88), stable housing (3.62; 95% CI 3.08-4.26), first treatment episode (OR 1.72; 95% CI 1.57-1.87), recent daily primary substance use (OR 1.46; 95% CI 1.33-1.59) and mono substance use (OR 1.23; 95% CI 1.04-1.48). Type of substance use was a significant determinant with higher odds of using pharmaceuticals (and alcohol) (OR 1.24; 95% CI 1.04-1.48), and lower odds of using cannabis only/primarily (OR 0.73; 95% CI 0.62-0.86), with reference to street drugs minus cannabis only/primarily. According to SGP data (n=314), determinants of starting GP treatment without concurrent specialist treatment were recent employment (OR 2.58; 95% CI 1.36-4.91), first treatment episode (OR 2.78; 95% CI 1.39-5.55) and living in the Brussels or Walloon region (OR 1.97; 95% CI 1.06-3.66).ConclusionsThis study adds knowledge about the general practice population treated for substance use problems and the consistency of data from the surveillances. Both studies show a relatively favourable profile of general practice patients with substance use problems.

Predictors of engagement in continuing care following residential substance use disorder treatment

2006 ◽  
Vol 84 (1) ◽  
pp. 93-101 ◽  
Author(s):  
Alex H.S. Harris ◽  
John D. McKellar ◽  
Rudolf H. Moos ◽  
Jeanne A. Schaefer ◽  
Ruth C. Cronkite
Keyword(s):  
Substance Use ◽  
Substance Use Disorder ◽  
Continuing Care ◽  
Substance Use Disorder Treatment ◽  
Disorder Treatment

scholarly journals General practice patients starting treatment for substance use problems: observations from two data sources across levels of care

2020 ◽  
Author(s):  
Nicole Boffin ◽  
Jerome Antoine ◽  
Luk Van Baelen ◽  
Sarah Moreels ◽  
Kris Doggen
Keyword(s):  
General Practice ◽  
Substance Use ◽  
Data Sources ◽  
Treatment Episode ◽  
Specialist Care ◽  
Levels Of Care ◽  
Monitoring Centre ◽  
Substance Use Problems ◽  
Treatment Demand ◽  
Specialist Treatment

Abstract Background In Belgium, the incidence of treatment episodes for substance use problems is monitored by the Network of Sentinel General Practices (SGP) and by the Treatment Demand Indicator (TDI) surveillance at higher, specialist care levels. Using both data sources, we examine 1) how patients starting specialist treatment for substance use problems on referral by their GP compare to those that were referred by non-GP caregivers; 2) how patients starting GP treatment for substance use problems without receiving specialist treatment concurrently compare to those who do. Methods Both surveillances are based on the TDI protocol for reporting data to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on persons starting treatment as a result of their substance use. Data from 2016 and 2017 were examined using 95% confidence intervals and multivariate logistic regression. Results According to TDI-data (n=16,543), determinants of being referred by a GP (versus by a non-GP caregiver) for specialist treatment were age ≥ median (OR 1.25; 95% CI 1.13-1.38), education ≥ secondary level (OR 1.27; 95% CI 1.15-1.41), recent employment (OR 1.71; 1.56-1.88), stable housing (3.62; 95% CI 3.08-4.26), first treatment episode (OR 1.72; 95% CI 1.57-1.87), recent daily primary substance use (OR 1.46; 95% CI 1.33-1.59) and mono substance use (OR 1.23; 95% CI 1.04-1.48). Type of substance use was a significant determinant with higher odds of using pharmaceuticals (and alcohol) (OR 1.24; 95% CI 1.04-1.48), and lower odds of using cannabis only/primarily (OR 0.73; 95% CI 0.62-0.86), with reference to street drugs minus cannabis only/primarily. According to SGP data (n=314), determinants of starting GP treatment without concurrent specialist treatment were recent employment (OR 2.58; 95% CI 1.36-4.91), first treatment episode (OR 2.78; 95% CI 1.39-5.55) and living in the Brussels or Walloon region (OR 1.97; 95% CI 1.06-3.66). Conclusions This study adds knowledge about the general practice population treated for substance use problems. It shows that both surveillances consistently found a relatively favourable profile of general practice patients with substance use problems.

scholarly journals General practice patients starting treatment for substance use problems: observations from two data sources across levels of care

2020 ◽  
Author(s):  
Nicole Boffin ◽  
Jerome Antoine ◽  
Luk Van Baelen ◽  
Sarah Moreels ◽  
Kris Doggen
Keyword(s):  
General Practice ◽  
Substance Use ◽  
Data Sources ◽  
Treatment Episode ◽  
Specialist Care ◽  
Levels Of Care ◽  
Monitoring Centre ◽  
Substance Use Problems ◽  
Treatment Demand ◽  
Specialist Treatment

Abstract Background In Belgium, the incidence of treatment episodes for substance use problems is monitored by the Network of Sentinel General Practices (SGP), and at higher, specialist care levels by the Treatment Demand Indicator (TDI) surveillance. Using both data sources, we examine 1) how patients starting specialist treatment for substance use problems on referral by their GP compare to those that were referred by non-GP caregivers; 2) how patients starting GP treatment for substance use problems without receiving concurrent specialist treatment compare to those who did. Methods Both surveillances are based on the TDI protocol for reporting data to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on individuals starting treatment as a result of their substance use. Data from 2016 and 2017 were examined using 95% confidence intervals and multivariate logistic regression. Results According to TDI-data (n=16,543), determinants of being referred by a GP (versus by a non-GP caregiver) for specialist treatment were age ≥ median (OR 1.25; 95% CI 1.13-1.38), education ≥ secondary level (OR 1.27; 95% CI 1.15-1.41), recent employment (OR 1.71; 1.56-1.88), recent stable accommodation (3.62; 95% CI 3.08-4.26), first treatment episode (OR 1.72; 95% CI 1.57-1.87), recent daily primary substance use (OR 1.46; 95% CI 1.33-1.59) and mono substance use (OR 1.23; 95% CI 1.04-1.48). Type of substance use was a significant determinant with higher odds of using pharmaceuticals (and alcohol) (OR 1.24; 95% CI 1.04-1.48), and lower odds of using cannabis only/primarily (OR 0.73; 95% CI 0.62-0.86), with reference to street drugs minus cannabis only/primarily. According to SGP data (n=314), determinants of starting GP treatment without concurrent specialist treatment were recent employment (OR 2.58; 95% CI 1.36-4.91), first treatment episode (OR 2.78; 95% CI 1.39-5.55) and living in the Brussels or Walloon region (OR 1.97; 95% CI 1.06-3.66). Conclusions This study provides a useful insight into the general practice population treated for substance use problems. It shows that both surveillances consistently found a relatively favourable profile of general practice patients with substance use problems.

scholarly journals General practice patients starting treatment for substance use problems: observations from two data sources across levels of care

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Nicole Boffin ◽  
Jerome Antoine ◽  
Luk Van Baelen ◽  
Sarah Moreels ◽  
Kris Doggen
Keyword(s):  
General Practice ◽  
Substance Use ◽  
Data Sources ◽  
Levels Of Care ◽  
Substance Use Problems

Continuity of Care Practices and Substance Use Disorder Patients??? Engagement in Continuing Care

Medical Care ◽  
2005 ◽  
Vol 43 (12) ◽  
pp. 1234-1241 ◽  
Author(s):  
Jeanne A. Schaefer ◽  
Erin Ingudomnukul ◽  
Alex H. S. Harris ◽  
Ruth C. Cronkite
Keyword(s):  
Substance Use ◽  
Substance Use Disorder ◽  
Continuity Of Care ◽  
Continuing Care ◽  
Care Practices

scholarly journals Targeting the Barriers in the Substance Use Disorder Continuum of Care With Peer Recovery Support

2021 ◽  
Vol 15 ◽  
pp. 117822182097698
Author(s):  
Milena Stanojlović ◽  
Larry Davidson
Keyword(s):  
Substance Use ◽  
Substance Use Disorder ◽  
Recovery Process ◽  
Continuum Of Care ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Care Continuum ◽  
Cascade Of Care ◽  
Recovery Support ◽  
The Continuum

Substance Use Disorder (SUD) has been recognized as a chronic, relapsing disorder. However, much of existing SUD care remains based in an acute care model that focuses on clinical stabilization and discharge, failing to address the longer-term needs of people in recovery from addiction. The high rates of client’s disengagement and attrition across the continuum of care highlight the need to identify and overcome the obstacles that people face at each stage of the treatment and recovery process. Peer recovery support services (PRSS) show promise in helping people initiate, pursue, and sustain long-term recovery from substance-related problems. Based on a comprehensive review of the literature, the goal of this article is to explore the possible roles of peers along the SUD care continuum and their potential to improve engagement in care by targeting specific barriers that prevent people from successfully transitioning from one stage to the next leading eventually to full recovery. A multidimensional framework of SUD care continuum was developed based on the adapted model of opioid use disorder cascade of care and recovery stages, within which the barriers known to be associated with each stage of the continuum were matched with the existing evidence of effectiveness of specific PRSSs. With this conceptual paper, we are hoping to show how PRSSs can become a complementary and integrated part of the system of care, which is an essential step toward improving the continuity of care and health outcomes.

Sign in / Sign up

Export Citation Format

Share Document